# Trastuzumab Therapy in Non-Small Cell Lung Cancer Patients

> **NCT00758134** · PHASE2 · TERMINATED · sponsor: **Armando Santoro, MD** · enrollment: 9 (actual)

## Conditions studied

- NON-SMALL CELL LUNG CANCER

## Interventions

- **DRUG:** Trastuzumab (Herceptin)

## Key facts

- **NCT ID:** NCT00758134
- **Lead sponsor:** Armando Santoro, MD
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2008-07
- **Primary completion:** 2010-06
- **Final completion:** 2010-12
- **Target enrollment:** 9 (ACTUAL)
- **Why stopped:** Insufficient accrual
- **Last updated:** 2013-05-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00758134

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00758134, "Trastuzumab Therapy in Non-Small Cell Lung Cancer Patients". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00758134. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*